Lumosa Therapeutics Revenue

Lumosa Therapeutics had revenue of 8.90M TWD in the quarter ending March 31, 2025, with 99.33% growth. This brings the company's revenue in the last twelve months to 43.59M, down -18.38% year-over-year. In the year 2024, Lumosa Therapeutics had annual revenue of 39.15M, down -31.21%.

Revenue (ttm)

43.59M

Revenue Growth

-18.38%

P/S Ratio

542.23

Revenue / Employee

1.01M

Employees

Market Cap

23.63B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	39.15M	-17.76M	-31.21%
Dec 31, 2023	56.92M	30.27M	113.63%
Dec 31, 2022	26.64M	9.28M	53.45%
Dec 31, 2021	17.36M	-4.29M	-19.81%
Dec 31, 2020	21.65M	-150.39M	-87.42%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Caliway Biopharmaceuticals	40.47M
PharmaEssentia	11.34B
Bora Pharmaceuticals Co., LTD.	20.87B
Lotus Pharmaceutical	19.12B
Polaris Group	87.67M
Oneness Biotech	117.33M
Center Laboratories	1.63B
TaiMed Biologics	607.46M

Revenue Rankings